Cargando…
Oncogenic Gain of Function in Glioblastoma Is Linked to Mutant p53 Amyloid Oligomers
Tumor-associated p53 mutations endow cells with malignant phenotypes, including chemoresistance. Amyloid-like oligomers of mutant p53 transform this tumor suppressor into an oncogene. However, the composition and distribution of mutant p53 oligomers are unknown and the mechanism involved in the conv...
Autores principales: | Pedrote, Murilo M., Motta, Michelle F., Ferretti, Giulia D.S., Norberto, Douglas R., Spohr, Tania C.L.S., Lima, Flavia R.S., Gratton, Enrico, Silva, Jerson L., de Oliveira, Guilherme A.P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6976948/ https://www.ncbi.nlm.nih.gov/pubmed/31981923 http://dx.doi.org/10.1016/j.isci.2020.100820 |
Ejemplares similares
-
Loss of the p53 transactivation domain results in high amyloid aggregation of the Δ40p53 isoform in endometrial carcinoma cells
por: Melo dos Santos, Nataly, et al.
Publicado: (2019) -
Aggregation tendencies in the p53 family are modulated by backbone hydrogen bonds
por: Cino, Elio A., et al.
Publicado: (2016) -
Aggregation-primed molten globule conformers of the p53 core domain provide potential tools for studying p53C aggregation in cancer
por: Pedrote, Murilo M., et al.
Publicado: (2018) -
Phase separation of p53 precedes aggregation and is affected by oncogenic mutations and ligands
por: Petronilho, Elaine C., et al.
Publicado: (2021) -
Mutant p53 Aggregates into Prion-like Amyloid Oligomers and Fibrils: IMPLICATIONS FOR CANCER
por: Ano Bom, Ana P. D., et al.
Publicado: (2012)